United Therapeutics: TYVASO DPI (NDA214324) SUPPL 7 approvedSep 23Regulatory decisiontreprostinilUnited TherapeuticsRecord notice
Insmed registers Phase 3 trial of inhaled TPIP for progressive pulmonary fibrosisSep 4Trial updateInsmed Incorporatedtreprostinil palmitil inhalation
FDA grants Fast Track designation to Liquidia's YUTREPIA for SSc-related Raynaud's phenomenonSep 3Regulatory milestoneLiquidia Corptreprostinil
Liquidia reports YUTREPIA sales growth, begins enrollment in L606 pivotal studyAug 12Quarterly updateLiquidia Corptreprostinil
United Therapeutics files two rare pulmonary disease NDAs, sets sights on approvals in 2027Aug 5Quarterly updateralinepagtreprostinil
FDA approves manufacturing supplement for Orenitram tablets from UNITED THERAPAug 4Regulatory decisiontreprostinilUnited Therapeutics
Insmed reports 12-month OLE data for TPIP in pulmonary arterial hypertensionJul 16Clinical readoutInsmed Incorporated
Sign inSign in